Respiratory distress syndrome (RDS) in premature infants is underscored by the magnitude of Th1 cytokine polarization

Cytokine

Volumn 58, Issue 3, 2012, Pages 355-360

  Varvarigou, Anastasia A ^a   Thomas, Iason ^b   Rodi, Maria ^b   Economou, Ioulia ^a   Mantagos, Stefanos ^a   Mouzaki, Athanasia ^b  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Cytokines; Human; Neonates; Respiratory distress syndrome; Surfactant

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LUNG SURFACTANT; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTRACHEAL TUBE; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LUNG HEMORRHAGE; MALE; MORTALITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; OUTCOME ASSESSMENT; OXYGENATION; PATHOGENESIS; POLARIZATION; PREMATURITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TH1 CELL; TH2 CELL; UMBILICAL CORD BLOOD;

CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PROGNOSIS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TH1 CELLS;

EID: 84860341497     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.03.005     Document Type: Article

References (25)

1. Goldenberg R.L., Culhane J.F., Iams J.D., Romero R. Epidemiology and causes of preterm birth. Lancet 2008, 371:75-84.
2. Ananth C.V., Vintzileos A.M. Epidemiology of preterm birth and its clinical subtypes. J Matern Fetal Neonatal Med 2006, 19:773-782.
3. Whitsett J.A., Pryhuber G.S., Rice W.R., Warner B.B., Wert S.E. Acute respiratory disorders. Neonatology: pathophysiology and management of the newborn 1994, 429-452. J.B. Lippincott Company, Philadelphia. 4th ed. G.B. Avery, M.A. Fletcher, M.G. MacDonald (Eds.).
4. Rodriguez R.J. Management of respiratory distress syndrome: an update. Respir Care 2003, 48:279-286.
5. Schwartz R.M., Luby A.M., Scanlon J.W., Kellogg R.J. Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500-1500g. N Engl J Med 1994, 330:1476-1480.
6. Raju T.N., Langenberg P. Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis. J Pediatr 1993, 123:603-610.
7. Aziz A, Ohlsson A. Surfactant for pulmonary hemorrhage in neonates. Cochrane Database Syst Rev 2008:CD005254.
8. Findlay R.D., Taeusch H.W., David-Cu R., Walther F.J. Lysis of red blood cells and alveolar epithelial toxicity by therapeutic pulmonary surfactants. Pediatr Res 1995, 37:26-30.
9. Bagchi A., Viscardi R.M., Taciak V., Ensor J.E., McCrea K.A., Hasday J.D. Increased activity of interleukin-6 but not tumor necrosis factor-alpha in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res 1994, 36:244-252.
10. Kotecha S., Wilson L., Wangoo A., Silverman M., Shaw R.J. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 1996, 40:250-256.
11. Buron E., Garrote J.A., Arranz E., Oyaguez P., Fernandez Calvo J.L., Blanco Q.A. Markers of pulmonary inflammation in tracheobronchial fluid of premature infants with respiratory distress syndrome. Allergol Immunopathol (Madr) 1999, 27:11-17.
12. Lista G., Castoldi F., Bianchi S., Battaglioli M., Cavigioli F., Bosoni M.A. Volume guarantee versus high-frequency ventilation: lung inflammation in preterm infants. Arch Dis Child Fetal Neonatal Ed 2008, 93:F252-F256.
13. Xia Y.F., Liu C.Q., Shi H.J., Ma L. Interleukin-4 and interleukin-13 concentrations in bronchoalveolar lavage fluid in neonates with respiratory distress syndrome and concurrent ventilator-associated pneumonia. Zhongguo Dang Dai Er Ke Za Zhi 2009, 11:645-648.
14. Shimoya K., Taniguchi T., Matsuzaki N., Moriyama A., Murata Y., Kitajima H., et al. Chorioamnionitis decreased incidence of respiratory distress syndrome by elevating fetal interleukin-6 serum concentration. Hum Reprod 2000, 15:2234-2240.
15. Gitto E., Reiter R.J., Amodio A., Romeo C., Cuzzocrea E., Sabatino G., et al. Early indicators of chronic lung disease in preterm infants with respiratory distress syndrome and their inhibition by melatonin. J Pineal Res 2004, 36:250-255.
16. Satar M., Turhan E., Yapicioglu H., Narli N., Ozgunen F.T., Cetiner S. Cord blood cytokine levels in neonates born to mothers with prolonged premature rupture of membranes and its relationship with morbidity and mortality. Eur Cytokine Netw 2008, 19:37-41.
17. Lista G., Castoldi F., Fontana P., Daniele I., Cavigioli F., Rossi S., et al. Nasal continuous positive airway pressure (CPAP) versus bi-level nasal CPAP in preterm babies with respiratory distress syndrome: a randomised control trial. Arch Dis Child Fetal Neonatal Ed 2010, 95:F85-F89.
18. Sorokin Y., Romero R., Mele L., Wapner R.J., Iams J.D., Dudley D.J., et al. Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32weeks and adverse neonatal outcomes. Am J Perinatol 2010, 27:631-640.
19. Benzer D., Aygun A.D., Godekmerdan A., Kurt A.N., Akarsu S., Yilmaz E. Serum endothelin-1 and transforming growth factor-beta levels in the newborns with respiratory distress. Mediators Inflamm 2006, 2006:1-5. art.ID.85432.
20. Ferreira P.J., Bunch T.J., Albertine K.H., Carlton D.P. Circulating neutrophil concentration and respiratory distress in premature infants. J Pediatr 2000, 136:466-472.
21. Speer C.P. Inflammatory mechanisms in neonatal chronic lung disease. Eur J Pediatr 1999, 158(Suppl. 1):S18-S22.
22. Turunen R., Vaarala O., Nupponen I., Kajantie E., Siitonen S., Lano A., et al. Activation of T cells in preterm infants with respiratory distress syndrome. Neonatology 2009, 96:248-258.
23. Halonen M., Lohman I.C., Stern D.A., Spangenberg A., Anderson D., Mobley S., et al. Th1/Th2 patterns and balance in cytokine production in the parents and infants of a large birth cohort. J Immunol 2009, 182:3285-3293.
24. Kerecman J., Mustafa S.B., Vasquez M.M., Dixon P.S., Castro R. Immunosuppressive properties of surfactant in alveolar macrophage NR8383. Inflamm Res 2008, 57:118-125.
25. Blanco-Quiros A., Arranz E., Solis G., Garrote J.A., Mayo A. High cord blood IL-10 levels in preterm newborns with respiratory distress syndrome. Allergol Immunopathol (Madr) 2004, 32:189-196.